Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other financing activities (2016 - 2020)

Historic Other financing activities for Veracyte (VCYT) over the last 4 years, with Q3 2020 value amounting to $3.3 million.

  • Veracyte's Other financing activities fell 2133.74% to $3.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $14.0 million, marking a year-over-year increase of 9853.86%. This contributed to the annual value of $129000.0 for FY2014, which is 9816.21% down from last year.
  • As of Q3 2020, Veracyte's Other financing activities stood at $3.3 million, which was down 2133.74% from $3.8 million recorded in Q2 2020.
  • In the past 5 years, Veracyte's Other financing activities registered a high of $4.2 million during Q3 2019, and its lowest value of $148000.0 during Q1 2016.
  • For the 3-year period, Veracyte's Other financing activities averaged around $2.8 million, with its median value being $3.3 million (2020).
  • Within the past 5 years, the most significant YoY rise in Veracyte's Other financing activities was 4107.95% (2020), while the steepest drop was 2133.74% (2020).
  • Quarter analysis of 3 years shows Veracyte's Other financing activities stood at $148000.0 in 2016, then skyrocketed by 2759.46% to $4.2 million in 2019, then fell by 21.34% to $3.3 million in 2020.
  • Its Other financing activities stands at $3.3 million for Q3 2020, versus $3.8 million for Q2 2020 and $4.2 million for Q3 2019.